Top 12 FAQs About Drug Regulatory Affairs in China
This blog talks about answers to the top 12 FAQs on drug regulatory affairs in China (2025 update), guiding compliance, approvals, and NMPA strategies.
https://www.freyrsolutions.com..../blog/top-12-frequen

Query Handling & Life Cycle Management (LCM) Support
This blog talks about how Freyr’s regulatory experts in Australia ensure seamless TGA query handling and life-cycle management support to be compliant.
https://www.freyrsolutions.com..../blog/query-handling

Japanese Clinical Data: Proving Comparability with Caucasian Populations
This blog talks about the necessity of Japanese clinical data to demonstrate comparability with Caucasian populations, guiding global regulatory strategies.
https://www.freyrsolutions.com..../blog/necessity-of-j

How Will NMPA’s 2025 eCTD Update Impact Your Product Launch Timeline?
This blog talks about how the NMPA’s 2025 eCTD update will affect your product launch timeline, highlighting streamlined processes, consistency, and enhanced lifecycle management.
https://www.freyrsolutions.com..../blog/how-will-nmpas

General Principles for Planning and Design of Multi-Regional Clinical Trials
This blog talks about the ICH E17-GL guideline’s harmonized framework for planning and designing multi-regional clinical trials to foster global drug approval.
https://www.freyrsolutions.com..../blog/ich-e17-gl-gen